Tumour ploidy and prognosis in carcinomas of the bladder and prostate.
作者信息
Tavares A S, Costa J, de Carvalho A, Reis M
出版信息
Br J Cancer. 1966 Sep;20(3):438-41. doi: 10.1038/bjc.1966.53.
Abstract
摘要
相似文献
1
Tumour ploidy and prognosis in carcinomas of the bladder and prostate.膀胱和前列腺癌中的肿瘤倍体与预后
Br J Cancer. 1966 Sep;20(3):438-41. doi: 10.1038/bjc.1966.53.
2
Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.膀胱癌DNA流式细胞术预后重要性的回顾性研究
J Clin Pathol. 1988 Jan;41(1):21-5. doi: 10.1136/jcp.41.1.21.
3
CARCINOMA ORIGINATING IN DUCTS SURROUNDING THE PROSTATIC URETHRA.起源于前列腺尿道周围导管的癌
Am J Clin Pathol. 1963 Aug;40:183-9. doi: 10.1093/ajcp/40.2.183.
4
[The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].[膀胱癌的DNA含量与病理分级、分期及预后的关系：一项流式细胞术研究]
Zhonghua Wai Ke Za Zhi. 1989 Nov;27(11):650-3, 700.
5
Markers of prognosis in superficial bladder cancer.浅表性膀胱癌的预后标志物
Semin Urol. 1992 Feb;10(1):28-38.
6
Urothelial carcinoma of the prostate.前列腺尿路上皮癌
Appl Pathol. 1985;3(4):242-54.
7
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.胎盘S100（S100P）和GATA3：通过互补DNA微阵列发现的移行上皮和尿路上皮癌标志物。
Am J Surg Pathol. 2007 May;31(5):673-80. doi: 10.1097/01.pas.0000213438.01278.5f.
8
Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.膀胱癌DNA倍体的肿瘤内异质性
Oncology. 1992;49(3):219-22. doi: 10.1159/000227042.
9
[DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
Nihon Rinsho. 1992 Oct;50(10):2426-31.
10
[Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].[膀胱移行细胞癌中DNA含量的预后意义]
Zhonghua Zhong Liu Za Zhi. 1992 Jan;14(1):24-6.
引用本文的文献
1
The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity.染色体不稳定性（CIN）、转移、炎症与肿瘤免疫之间新出现的联系。
Mol Cytogenet. 2019 May 14;12:17. doi: 10.1186/s13039-019-0429-1. eCollection 2019.
2
Quantitative pathology: historical background, clinical research and application of nuclear morphometry and DNA image cytometry.定量病理学：核形态计量学和DNA图像细胞术的历史背景、临床研究与应用
Libyan J Med. 2006 Sep 20;1(2):126-39. doi: 10.4176/060911.
3
Prognostic factors in prostate cancer.前列腺癌的预后因素。
Diagn Pathol. 2006 Apr 3;1:4. doi: 10.1186/1746-1596-1-4.
4
DNA-ploidy, G2M-fractions and prognosis of stages B and C prostate carcinoma.DNA倍体、G2M期比例与B期和C期前列腺癌的预后
Virchows Arch. 1994;424(6):647-51. doi: 10.1007/BF00195780.
5
DNA profile and tumour progression in patients with superficial bladder tumours.浅表性膀胱肿瘤患者的DNA图谱与肿瘤进展
Urol Res. 1982 Feb;10(1):13-8. doi: 10.1007/BF00256518.
6
Papillary carcinoma of the urinary bladder. A study of chromosomal and cytofluorometric DNA analysis.膀胱乳头状癌。染色体及细胞荧光光度法DNA分析研究。
Urol Res. 1980;8(2):87-93. doi: 10.1007/BF00271434.
7
Clinical and biological significance of aneuploidy in human tumours.人类肿瘤中非整倍体的临床及生物学意义。
J Clin Pathol. 1984 Sep;37(9):961-74. doi: 10.1136/jcp.37.9.961.
8
Preoperative detection of a highly malignant type of early gastric carcinoma by cytophotometric DNA analysis.通过细胞光度法DNA分析对高恶性早期胃癌进行术前检测。
Jpn J Surg. 1986 May;16(3):169-74. doi: 10.1007/BF02471089.
9
Aneuploidy of glandular epithelial cells in histologically normal prostate glands.组织学正常的前列腺腺体内腺上皮细胞的非整倍体现象。
Experientia. 1988 Mar 15;44(3):247-9. doi: 10.1007/BF01941724.
10
Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.基于1465例病例探讨恶性肿瘤中DNA含量众数及其他因素的预后意义。
Br J Cancer. 1979 Aug;40(2):210-21. doi: 10.1038/bjc.1979.168.
本文引用的文献
1
[Cell nuclear morphological sex in breast and prostate carcinoma].
Klin Wochenschr. 1957 Oct 1;35(19):985. doi: 10.1007/BF01484483.
Zotero 插件